FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:1493-1495 November 15, 2001 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Mohr, J.P. PubMed Citation

This year in the United States, 450,000 people will have a first ischemic stroke.^1,2,3 For these patients (including those receiving thrombolytic therapy), the primary therapeutic goals will be rehabilitation and the prevention of another stroke. The optimal preventive therapy should be determined on the basis of the results of randomized, controlled trials. Trials have demonstrated that selected patients with an ischemic stroke in the territory of a stenotic carotid artery have a lower risk of recurrence if they are treated with carotid endarterectomy, rather than with antiplatelet therapy.⁴ Patients with atrial fibrillation have a lower risk of recurrence with oral . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Schachter, M. E, Tran, H. A, Anand, S. S (2008). Oral anticoagulants and non-cardioembolic stroke prevention. Vasc Med 13: 55-62 [Abstract]  
• de Abreu, T. T., Mateus, S., Correia, J. (2005). Therapy Implications of Transthoracic Echocardiography in Acute Ischemic Stroke Patients. Stroke 36: 1565-1566 [Abstract] [Full Text]  
• Gorelick, P. B., Richardson, D., Kelly, M., Ruland, S., Hung, E., Harris, Y., Kittner, S., Leurgans, S. (2003). Aspirin and Ticlopidine for Prevention of Recurrent Stroke in Black Patients: A Randomized Trial. JAMA 289: 2947-2957 [Abstract] [Full Text]  
• Lewis, S. C., Sandercock, P. A.G., Algra, A., the European-Australian Stroke Prevention in Rever, , Hsi, D. H., Alaimo, D. J., Butera, G., Chessa, M., Carminati, M., Mohr, J.P., Thompson, J.L.P., Levin, B., the Warfarin-Aspirin Recurrent Stroke Study Group, , Powers, W. J. (2002). Warfarin or Aspirin for Recurrent Ischemic Stroke. NEJM 346: 1169-1171 [Full Text]